1 Irritable Bowel Syndrome with Constipation Drugs Market Overview 1.1 Product Overview and Scope of Irritable Bowel Syndrome with Constipation Drugs 1.2 Irritable Bowel Syndrome with Constipation Drugs Segment by Type 1.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Lubiprostone 1.2.3 Linaclotide 1.2.4 Stimulant Laxatives 1.2.5 Osmotic Laxatives 1.2.6 Others 1.3 Irritable Bowel Syndrome with Constipation Drugs Segment by Application 1.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Irritable Bowel Syndrome with Constipation Drugs Market Size Estimates and Forecasts 1.4.1 Global Irritable Bowel Syndrome with Constipation Drugs Revenue 2016-2027 1.4.2 Global Irritable Bowel Syndrome with Constipation Drugs Sales 2016-2027 1.4.3 Irritable Bowel Syndrome with Constipation Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Irritable Bowel Syndrome with Constipation Drugs Market Competition by Manufacturers 2.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Irritable Bowel Syndrome with Constipation Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Irritable Bowel Syndrome with Constipation Drugs Manufacturing Sites, Area Served, Product Type 2.5 Irritable Bowel Syndrome with Constipation Drugs Market Competitive Situation and Trends 2.5.1 Irritable Bowel Syndrome with Constipation Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Irritable Bowel Syndrome with Constipation Drugs Players Market Share by Revenue 2.5.3 Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Irritable Bowel Syndrome with Constipation Drugs Retrospective Market Scenario by Region 3.1 Global Irritable Bowel Syndrome with Constipation Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Irritable Bowel Syndrome with Constipation Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures by Country 3.3.1 North America Irritable Bowel Syndrome with Constipation Drugs Sales by Country 3.3.2 North America Irritable Bowel Syndrome with Constipation Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures by Country 3.4.1 Europe Irritable Bowel Syndrome with Constipation Drugs Sales by Country 3.4.2 Europe Irritable Bowel Syndrome with Constipation Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Sales by Region 3.5.2 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures by Country 3.6.1 Latin America Irritable Bowel Syndrome with Constipation Drugs Sales by Country 3.6.2 Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Sales by Country 3.7.2 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Analysis by Type 4.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2016-2021) 4.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Irritable Bowel Syndrome with Constipation Drugs Price by Type (2016-2021) 5 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Analysis by Application 5.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2016-2021) 5.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Irritable Bowel Syndrome with Constipation Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Nestle 6.1.1 Nestle Corporation Information 6.1.2 Nestle Description and Business Overview 6.1.3 Nestle Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Nestle Irritable Bowel Syndrome with Constipation Drugs Product Portfolio 6.1.5 Nestle Recent Developments/Updates 6.2 Abbot Laboratories 6.2.1 Abbot Laboratories Corporation Information 6.2.2 Abbot Laboratories Description and Business Overview 6.2.3 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Product Portfolio 6.2.5 Abbot Laboratories Recent Developments/Updates 6.3 Synergy Pharmaceuticals 6.3.1 Synergy Pharmaceuticals Corporation Information 6.3.2 Synergy Pharmaceuticals Description and Business Overview 6.3.3 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Portfolio 6.3.5 Synergy Pharmaceuticals Recent Developments/Updates 6.4 Sucampo Pharmaceuticals 6.4.1 Sucampo Pharmaceuticals Corporation Information 6.4.2 Sucampo Pharmaceuticals Description and Business Overview 6.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Portfolio 6.4.5 Sucampo Pharmaceuticals Recent Developments/Updates 6.5 Novartis 6.5.1 Novartis Corporation Information 6.5.2 Novartis Description and Business Overview 6.5.3 Novartis Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Novartis Irritable Bowel Syndrome with Constipation Drugs Product Portfolio 6.5.5 Novartis Recent Developments/Updates 6.6 Astellas Pharmaceuticals 6.6.1 Astellas Pharmaceuticals Corporation Information 6.6.2 Astellas Pharmaceuticals Description and Business Overview 6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Portfolio 6.6.5 Astellas Pharmaceuticals Recent Developments/Updates 7 Irritable Bowel Syndrome with Constipation Drugs Manufacturing Cost Analysis 7.1 Irritable Bowel Syndrome with Constipation Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs 7.4 Irritable Bowel Syndrome with Constipation Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Irritable Bowel Syndrome with Constipation Drugs Distributors List 8.3 Irritable Bowel Syndrome with Constipation Drugs Customers 9 Irritable Bowel Syndrome with Constipation Drugs Market Dynamics 9.1 Irritable Bowel Syndrome with Constipation Drugs Industry Trends 9.2 Irritable Bowel Syndrome with Constipation Drugs Growth Drivers 9.3 Irritable Bowel Syndrome with Constipation Drugs Market Challenges 9.4 Irritable Bowel Syndrome with Constipation Drugs Market Restraints 10 Global Market Forecast 10.1 Irritable Bowel Syndrome with Constipation Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Irritable Bowel Syndrome with Constipation Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Constipation Drugs by Type (2022-2027) 10.2 Irritable Bowel Syndrome with Constipation Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Irritable Bowel Syndrome with Constipation Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Constipation Drugs by Application (2022-2027) 10.3 Irritable Bowel Syndrome with Constipation Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Irritable Bowel Syndrome with Constipation Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Constipation Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Irritable Bowel Syndrome with Constipation Drugs Covered in This Study Table 5. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Irritable Bowel Syndrome with Constipation Drugs Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Irritable Bowel Syndrome with Constipation Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Irritable Bowel Syndrome with Constipation Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Irritable Bowel Syndrome with Constipation Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome with Constipation Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Irritable Bowel Syndrome with Constipation Drugs Sales by Region (2016-2021) & (K MT) Table 16. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Region (2016-2021) Table 17. Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2016-2021) & (K MT) Table 19. North America Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Country (2016-2021) Table 20. North America Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2016-2021) & (K MT) Table 23. Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2016-2021) & (K MT) Table 31. Latin America Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2016-2021) Table 39. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2016-2021) Table 40. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Type (2016-2021) Table 42. Global Irritable Bowel Syndrome with Constipation Drugs Price (USD/MT) by Type (2016-2021) Table 43. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2016-2021) Table 44. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2016-2021) Table 45. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Application (2016-2021) Table 47. Global Irritable Bowel Syndrome with Constipation Drugs Price (USD/MT) by Application (2016-2021) Table 48. Nestle Corporation Information Table 49. Nestle Description and Business Overview Table 50. Nestle Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Nestle Irritable Bowel Syndrome with Constipation Drugs Product Table 52. Nestle Recent Developments/Updates Table 53. Abbot Laboratories Corporation Information Table 54. Abbot Laboratories Description and Business Overview Table 55. Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Product Table 57. Abbot Laboratories Recent Developments/Updates Table 58. Synergy Pharmaceuticals Corporation Information Table 59. Synergy Pharmaceuticals Description and Business Overview Table 60. Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Table 62. Synergy Pharmaceuticals Recent Developments/Updates Table 63. Sucampo Pharmaceuticals Corporation Information Table 64. Sucampo Pharmaceuticals Description and Business Overview Table 65. Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Table 67. Sucampo Pharmaceuticals Recent Developments/Updates Table 68. Novartis Corporation Information Table 69. Novartis Description and Business Overview Table 70. Novartis Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Novartis Irritable Bowel Syndrome with Constipation Drugs Product Table 72. Novartis Recent Developments/Updates Table 73. Astellas Pharmaceuticals Corporation Information Table 74. Astellas Pharmaceuticals Description and Business Overview Table 75. Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Table 77. Astellas Pharmaceuticals Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Irritable Bowel Syndrome with Constipation Drugs Distributors List Table 81. Irritable Bowel Syndrome with Constipation Drugs Customers List Table 82. Irritable Bowel Syndrome with Constipation Drugs Market Trends Table 83. Irritable Bowel Syndrome with Constipation Drugs Growth Drivers Table 84. Irritable Bowel Syndrome with Constipation Drugs Market Challenges Table 85. Irritable Bowel Syndrome with Constipation Drugs Market Restraints Table 86. Global Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by Type (2022-2027) & (K MT) Table 87. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share Forecast by Type (2022-2027) Table 88. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 89. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share Forecast by Type (2022-2027) Table 90. Global Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by Application (2022-2027) & (K MT) Table 91. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share Forecast by Application (2022-2027) Table 92. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 93. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share Forecast by Application (2022-2027) Table 94. Global Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by Region (2022-2027) & (K MT) Table 95. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share Forecast by Region (2022-2027) Table 96. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 97. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share Forecast by Region (2022-2027) Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Irritable Bowel Syndrome with Constipation Drugs Figure 2. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Type in 2020 & 2027 Figure 3. Lubiprostone Product Picture Figure 4. Linaclotide Product Picture Figure 5. Stimulant Laxatives Product Picture Figure 6. Osmotic Laxatives Product Picture Figure 7. Others Product Picture Figure 8. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Application in 2020 & 2027 Figure 9. Hospitals Figure 10. Clinics Figure 11. Others Figure 12. Global Irritable Bowel Syndrome with Constipation Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Irritable Bowel Syndrome with Constipation Drugs Market Size 2016-2027 (US$ Million) Figure 14. Global Irritable Bowel Syndrome with Constipation Drugs Sales 2016-2027 (K MT) Figure 15. Global Irritable Bowel Syndrome with Constipation Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Irritable Bowel Syndrome with Constipation Drugs Sales Share by Manufacturers in 2020 Figure 17. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Irritable Bowel Syndrome with Constipation Drugs Players: Market Share by Revenue in 2020 Figure 19. Irritable Bowel Syndrome with Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Region (2016-2021) Figure 21. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Region in 2020 Figure 22. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Region (2016-2021) Figure 23. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Region in 2020 Figure 24. U.S. Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Irritable Bowel Syndrome with Constipation Drugs by Type (2016-2021) Figure 49. Sales Market Share of Irritable Bowel Syndrome with Constipation Drugs by Application (2016-2021) Figure 50. Sales Market Share of Irritable Bowel Syndrome with Constipation Drugs by Application in 2020 Figure 51. Revenue Share of Irritable Bowel Syndrome with Constipation Drugs by Application (2016-2021) Figure 52. Revenue Share of Irritable Bowel Syndrome with Constipation Drugs by Application in 2020 Figure 53. Manufacturing Cost Structure of Irritable Bowel Syndrome with Constipation Drugs Figure 54. Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs Figure 55. Irritable Bowel Syndrome with Constipation Drugs Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Nestle Abbot Laboratories Synergy Pharmaceuticals Sucampo Pharmaceuticals Novartis Astellas Pharmaceuticals